In conclusion, we have identified key molecular mechanisms that control tumor suppressor MIR139 in MLL-AF9 leukemia and report functionally relevant targets of miR-139-mediated cell death of MLL-AF9 cells. The gene discussed is KMT2A; the disease is leukemia.